1. Home
  2. AERT vs ELUT Comparison

AERT vs ELUT Comparison

Compare AERT & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

N/A

Current Price

$7.10

Market Cap

39.7M

ML Signal

N/A

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.84

Market Cap

42.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERT
ELUT
Founded
2012
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Professional Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.7M
42.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
AERT
ELUT
Price
$7.10
$0.84
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $6.00
AVG Volume (30 Days)
14.7K
★ 42.9K
Earning Date
02-09-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
110.87
★ 146.77
EPS
★ 0.27
N/A
Revenue
★ $70,014,000.00
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.83
P/E Ratio
$26.81
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.26
$0.50
52 Week High
$7.65
$1.39

Technical Indicators

Market Signals
Indicator
AERT
ELUT
Relative Strength Index (RSI) 52.10 44.59
Support Level $6.11 $0.80
Resistance Level $7.30 $1.01
Average True Range (ATR) 0.28 0.07
MACD -0.00 0.00
Stochastic Oscillator 64.19 25.01

Price Performance

Historical Comparison
AERT
ELUT

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs. It has more than 40 clients spanning across industry segments.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: